Green View Magazine | December 2019

29 GREEN VIEW MAGAZINE DECEMBER 2019 GVM: How do you market the Cannabics solutions to investors? CNBX: “We place an emphasis on the importance of the mission we have set out to accomplish, which is to match the right cannabinoid composition to the right person. To achieve this, we approach investors by laying out the current issues and problems that cancer patients are faced with today, and how our solutions may help. Our investors come from a plethora of countries and territories, not necessarily from countries where medical cannabis is accessible and regulated. The promises that the plant holds are fascinating for anyone – for a variety of industries.” GVM: Are you involved in educating medical professionals about the benefits of cannabis? CNBX: “There continues to be a growing demand for cannabis in the medical landscape, especially on the palliative side of care. Those battling cancer – both patients and their physicians – are turning to cannabis in an effort to ease symptoms associated with the disease, as well as side effects